President Donald Trump signed an executive order on September 30, 2025 that doubles federal funding for AI-enabled pediatric cancer research by adding $50 million annually to the Childhood Cancer Data Initiative (CCDI) program.
The Childhood Cancer Data Initiative, originally launched during Trump’s first term in 2019, currently receives $50 million annually in federal funding as part of a decade-long commitment to childhood cancer research. The new executive order substantially boosts resources for AI applications in this critical area.
The Department of Health and Human Services confirmed the funding increase, stating that President Trump is “harnessing American innovation in artificial intelligence to find cures for pediatric cancer.” The initiative builds on the CCDI’s foundational data infrastructure to accelerate research over the coming years.
The executive order directs the Make America Healthy Again (MAHA) Commission, the Assistant to the President for Science and Technology, and the Special Advisor for AI and Crypto to develop and implement AI strategies in concert with the CCDI and HHS to advance childhood cancer research.
According to the White House fact sheet, AI has the potential to transform the current care and research approach for pediatric cancer by enhancing diagnosis accuracy, optimizing treatment protocols, discovering new cures, and improving prevention strategies. The technology is also being integrated into clinical trial design and outcomes through improved data analysis of complex biological systems.
The CCDI was originally proposed as part of a broader $500 million increase in childhood cancer funding over ten years announced during Trump’s 2019 State of the Union address. The initiative focuses on collecting, generating, and analyzing detailed, standardized childhood cancer data from across the United States to facilitate research and clinical care improvements.
The National Cancer Institute, which manages the CCDI, has been working since 2019 to build the foundational data infrastructure needed for advanced AI applications in pediatric cancer research. The recent executive order tasks agencies with identifying ways to better support and expand this data infrastructure and its utilization in clinical trials and research.